1. Home
  2. CRNX vs HLN Comparison

CRNX vs HLN Comparison

Compare CRNX & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRNX
  • HLN
  • Stock Information
  • Founded
  • CRNX 2008
  • HLN 2022
  • Country
  • CRNX United States
  • HLN United Kingdom
  • Employees
  • CRNX N/A
  • HLN N/A
  • Industry
  • CRNX Biotechnology: Pharmaceutical Preparations
  • HLN Package Goods/Cosmetics
  • Sector
  • CRNX Health Care
  • HLN Consumer Discretionary
  • Exchange
  • CRNX Nasdaq
  • HLN Nasdaq
  • Market Cap
  • CRNX 2.8B
  • HLN 48.2B
  • IPO Year
  • CRNX 2018
  • HLN N/A
  • Fundamental
  • Price
  • CRNX $30.00
  • HLN $10.25
  • Analyst Decision
  • CRNX Strong Buy
  • HLN Buy
  • Analyst Count
  • CRNX 10
  • HLN 1
  • Target Price
  • CRNX $75.00
  • HLN $10.95
  • AVG Volume (30 Days)
  • CRNX 646.9K
  • HLN 14.1M
  • Earning Date
  • CRNX 08-07-2025
  • HLN 07-31-2025
  • Dividend Yield
  • CRNX N/A
  • HLN 1.73%
  • EPS Growth
  • CRNX N/A
  • HLN 38.94
  • EPS
  • CRNX N/A
  • HLN 0.20
  • Revenue
  • CRNX $760,000.00
  • HLN $14,062,871,660.00
  • Revenue This Year
  • CRNX $402.12
  • HLN $3.63
  • Revenue Next Year
  • CRNX $770.88
  • HLN $4.37
  • P/E Ratio
  • CRNX N/A
  • HLN $25.66
  • Revenue Growth
  • CRNX N/A
  • HLN N/A
  • 52 Week Low
  • CRNX $24.10
  • HLN $8.37
  • 52 Week High
  • CRNX $62.53
  • HLN $11.42
  • Technical
  • Relative Strength Index (RSI)
  • CRNX 44.17
  • HLN 32.60
  • Support Level
  • CRNX $28.34
  • HLN $10.19
  • Resistance Level
  • CRNX $30.01
  • HLN $10.61
  • Average True Range (ATR)
  • CRNX 1.07
  • HLN 0.12
  • MACD
  • CRNX -0.17
  • HLN -0.05
  • Stochastic Oscillator
  • CRNX 36.41
  • HLN 8.11

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: